Successful Treatment of Catastrophic Antiphospholipid Syndrome Using Rituximab: Case Report and Review of the Literature.
Cristina StanescuAndreea Gabriella AndronesiCiprian JurcutMihaela GherghiceanuAlexandra VornicuFlorentina Andreea BurceaToader Danut AndronesiGabriela Elena LupusoruLuminita IliutaBogdan Marian SorohanBogdan ObrișcăGener IsmailPublished in: Medicina (Kaunas, Lithuania) (2021)
Targeted therapy was possible after kidney biopsy, improving renal and general prognosis. CD19+B-Ly repopulation preceded biological relapse, so monitoring of CD19+B-Ly may serve as a tool to predict relapses and guide rituximab therapy.